Delivery Order SPE2DB24D3013-SPE2DB25FFLNL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,075.18 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 ml pharmaceutical product. This firm fixed-price delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of September 19, 2025. The award represents a continuation of services under AmerisourceBergen's broader contract vehicle with DLA, leveraging the company's established...
- The Defense Logistics Agency awarded a $48,698.09 delivery order to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 mL pharmaceutical supplies. This firm fixed price, competitively awarded contract was executed on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework...
- The Defense Logistics Agency awarded a delivery order valued at $19,253.01 to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 mL pharmaceutical supplies. The contract, executed on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing and represents a non-set-aside competitive award. Performance will be conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $5,967.40 to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 ml pharmaceutical product on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract is a firm fixed price delivery order with no set-aside designation, and performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,863.20 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Actemra Actpen (162 mg/0.9 mL) pharmaceutical product. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was awarded competitively with no set-aside designation. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $7,609.13 to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 mL pharmaceutical product. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of July 30, 2025. The award was made on July 29, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,672.79 for Actemra Actpen 162 mg/0.9 mL pharmaceutical product, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,715.91 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 ml auto-injectors. This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,058.52 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL injectable medication. Issued on August 14, 2025, with an ultimate completion date of August 15, 2025, this firm fixed-price contract requires performance at the company's Conshohocken, Pennsylvania location. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at approximately $51,886 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen (162 mg/0.9 mL) pharmaceutical product, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract was issued on July 24, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The award includes no set-aside designation, reflecting open competition among...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFLNLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,111.54 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 ml pharmaceutical product. The contract, which is a child delivery order under a larger indefinite delivery vehicle, was awarded on May 8, 2025, with an ultimate completion date of May 9, 2025. The award utilized firm fixed pricing with no set-aside designation, indicating competitive procurement. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs and Defense Health Agency customers worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, regularly fulfills federal medical procurement requirements through DLA's Medical Supply Chain, demonstrating capability across multiple therapeutic domains and product categories through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 5/8/25 |